Lymph-vascular space invasion as a significant risk factor for isolated para-aortic lymph node metastasis in endometrial cancer: a study of 203 consecutive patients

Ann Surg Oncol. 2011 Jan;18(1):58-64. doi: 10.1245/s10434-010-1206-x. Epub 2010 Jul 7.

Abstract

Background: The purpose of this study was to investigate various pathologic risk factors associated with para-aortic lymph node metastasis (LNM) in surgically staged patients with endometrial cancer.

Materials and methods: We performed a retrospective analysis of 203 consecutive patients with endometrial cancer who were surgically staged from 2000 to 2009. The association among the various pathologic variables for para-aortic LNM was determined with univariate and multivariate analyses.

Results: Of 203 patients, 29 patients (14.3%) had LNM. Also, 10 patients (4.9%) had only pelvic LNM, 14 (6.9%) had both pelvic and para-aortic LNM, and 5 (2.5%) had para-aortic LNM without pelvic LN involvements. Histologic type (P = .001), tumor grade (P < .001), tumor size (P = .003), depth of myometrial invasion (P < .001), cervical invasion (P < .001), parametrial invasion (P = .002), lymph-vascular space invasion (LVSI) (P < .001), serosal/adnexal invasion (P < .001), positive cytology (P = .002), peritoneal seeding (P < .001), and pelvic LNM (P < .001) were significant pathologic factors for para-aortic LNM. On multivariate analysis, cervical invasion (P = .032), LVSI (P = .018), and positive pelvic LNs (P = .002) were independent factors for para-aortic LNM. With regard to isolated para-aortic LNM, tumor grade (P = .017) and LVSI (P = .002) were significant factors for LN involvements. On multivariate analysis, LVSI (P = .004) was the only significant independent factor.

Conclusions: LVSI correlates significantly with the risk of isolated para-aortic LNM in endometrial cancer patients.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Papillary / secondary*
  • Carcinoma, Papillary / surgery
  • Carcinosarcoma / secondary*
  • Carcinosarcoma / surgery
  • Cystadenocarcinoma, Serous / secondary*
  • Cystadenocarcinoma, Serous / surgery
  • Endometrial Neoplasms / pathology*
  • Endometrial Neoplasms / surgery
  • Female
  • Follow-Up Studies
  • Humans
  • Lymph Nodes / pathology*
  • Lymph Nodes / surgery
  • Lymphatic Metastasis
  • Lymphatic Vessels / pathology*
  • Lymphatic Vessels / surgery
  • Middle Aged
  • Neoplasm Invasiveness
  • Peritoneal Neoplasms / secondary*
  • Peritoneal Neoplasms / surgery
  • Retrospective Studies
  • Risk Factors
  • Survival Rate
  • Treatment Outcome